CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shanghai Xiao Fang Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shanghai Xiao Fang Pharmaceutical Co Ltd
No. 777, Hongzhu Road, Fengxian District
Phone: +86 2158207999p:+86 2158207999 SHANGHAI, SHA  201411  China Ticker: 603207603207
Business Summary
Shanghai Xiao Fang Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of external medicines. The Company's products cover digestive, skin and ophthalmic products. Digestive products mainly include enema, glycerin enema, and others. Skin products include calamine lotion, zinc oxide ointment, sulfur ointment, antispasmodic and analgesic tincture, chilblain ointment, compound menthol ointment, urea vitamin E cream, boric acid lotion, benzalkonium bromide tincture, white flower oil, salicylic acid ointment, and others. Ophthalmic products mainly include iodine glycerin, furan nasal drops, ofloxacin ear drops, and others. The Company's products are mainly used to treat constipation, dermatitis and eczema, acne bedsores, traumatic injuries, chilblains, sunburns and burns, tinea capitis, keratin hyperplasia, oral ulcers, gingival swelling and pain, periodontitis, rhinitis and nasal congestion, otitis media and other diseases.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023-----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Business Names
Business Name
603207
Shanghai Winguide Huangpu Pharmactcl Ltd

General Information
Number of Employees: 548 (As of 12/31/2023)
Outstanding Shares: 160,000,000 (As of 9/30/2024)
Stock Exchange: SHA
Fax Number: +86 2158202666


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024